Literature DB >> 17241750

Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer.

Nancy Lee1, James Mechalakos, Dev R Puri, Margie Hunt.   

Abstract

PURPOSE: With the emerging use of intensity-modulated radiation therapy (IMRT) in the treatment of head-and-neck cancer, selection of technique becomes a critical issue. The purpose of this article is to establish IMRT guidelines for head-and-neck cancer at a given institution. METHODS AND MATERIALS: Six common head-and-neck cancer cases were chosen to illustrate the points that must be considered when choosing between split-field (SF) IMRT, in which the low anterior neck (LAN) is treated with an anterior field, and the extended whole-field (EWF) IMRT in which the LAN is included with the IMRT fields. For each case, the gross tumor, clinical target, and planning target volumes and the surrounding critical normal tissues were delineated. Subsequently, the SF and EWF IMRT plans were compared using dosimetric parameters from dose-volume histograms.
RESULTS: Target coverage and doses delivered to the critical normal structures were similar between the two different techniques. Cancer involving the nasopharynx and oropharynx are best treated with the SF IMRT technique to minimize the glottic larynx dose. The EWF IMRT technique is preferred in situations in which the glottic larynx is considered as a target, i.e., cancer of the larynx, hypopharynx, and unknown head-and-neck primary. When the gross disease extends inferiorly and close to the glottic larynx, EWF IMRT technique is also preferred.
CONCLUSION: Depending on the clinical scenario, different IMRT techniques and guidelines are suggested to determine a preferred IMRT technique. We found that having this treatment guideline when treating these tumors ensures a smoother flow for the busy clinic.

Entities:  

Mesh:

Year:  2007        PMID: 17241750     DOI: 10.1016/j.ijrobp.2006.11.019

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

2.  IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Authors:  Gupta Tejpal; Agarwal Jaiprakash; Bannerjee Susovan; Sarbani Ghosh-Laskar; Vedang Murthy; Ashwini Budrukkar
Journal:  Indian J Surg Oncol       Date:  2010-11-21

3.  Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.

Authors:  Aruna Turaka; Tianyu Li; Nicos Nicolaou; Miriam N Lango; Barbara Burtness; Eric M Horwitz; John A Ridge; Steven J Feigenberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-10       Impact factor: 7.038

4.  Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.

Authors:  Benjamin H Lok; Jeremy Setton; Nicola Caria; Jonathan Romanyshyn; Suzanne L Wolden; Michael J Zelefsky; Jeffery Park; Nicholas Rowan; Eric J Sherman; Matthew G Fury; Alan Ho; David G Pfister; Richard J Wong; Jatin P Shah; Dennis H Kraus; Zhigang Zhang; Karen D Schupak; Daphna Y Gelblum; Shyam D Rao; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-02       Impact factor: 7.038

5.  Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy.

Authors:  Paul B Romesser; Jonathan C Romanyshyn; Karen D Schupak; Jeremy Setton; Nadeem Riaz; Suzanne L Wolden; Daphna Y Gelblum; Eric J Sherman; Dennis Kraus; Nancy Y Lee
Journal:  Cancer       Date:  2012-06-15       Impact factor: 6.860

6.  The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.

Authors:  Paul B Romesser; Remy Lim; Daniel E Spratt; Jeremy Setton; Nadeem Riaz; Benjamin Lok; Shyam Rao; Eric J Sherman; Heiko Schöder; Nancy Y Lee
Journal:  Oral Oncol       Date:  2014-07-17       Impact factor: 5.337

7.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.

Authors: 
Journal:  Radiother Oncol       Date:  2016-02-17       Impact factor: 6.280

8.  The minimum knowledge base for predicting organ-at-risk dose-volume levels and plan-related complications in IMRT planning.

Authors:  Hao H Zhang; Robert R Meyer; Leyuan Shi; Warren D D'Souza
Journal:  Phys Med Biol       Date:  2010-03-12       Impact factor: 3.609

9.  A surrogate-based metaheuristic global search method for beam angle selection in radiation treatment planning.

Authors:  H H Zhang; S Gao; W Chen; L Shi; W D D'Souza; R R Meyer
Journal:  Phys Med Biol       Date:  2013-03-21       Impact factor: 3.609

10.  A two-stage sequential linear programming approach to IMRT dose optimization.

Authors:  Hao H Zhang; Robert R Meyer; Jianzhou Wu; Shahid A Naqvi; Leyuan Shi; Warren D D'Souza
Journal:  Phys Med Biol       Date:  2010-01-14       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.